The largest database of trusted experimental protocols

Nucleofector 2 machine

Manufactured by Lonza
Sourced in United States, Germany

The Nucleofector II machine is a laboratory instrument designed for efficient transfection of a wide range of cell types, including difficult-to-transfect cells. It utilizes Lonza's proprietary Nucleofection technology to deliver nucleic acids, such as DNA and RNA, into the nucleus of cells. The machine features pre-optimized Nucleofector Solutions and Nucleofector Programs for a diverse range of cell lines and primary cells.

Automatically generated - may contain errors

7 protocols using nucleofector 2 machine

1

Cloning and Transfection of Viral Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Individual virus proteins were cloned into the pCAGGS vector containing a hemagglutinin tag at the N-terminus proximal to the insertion site (gift from Chris Basler) (44 (link)). The nsP and capsid proteolytic cleavage sites were chosen as the boundaries of the protein genes and a stop codon was added at the end of each gene. Viral genes were PCR-amplified from full-length cDNA clones using suitable primers with Not1 and Nhe1/Xma1 restriction sites added at the 5’ and 3’ ends respectively. Additionally, GFP was PCR-amplified from a previously constructed plasmid using suitable primers with Not1 and Nhe1 restriction sites added at the 5’ and 3’ ends respectively. PCR products and pCAGGS vector were digested and ligated, and individual clones were selected and confirmed by restriction digestion and sequencing. Huh7 and MEF cells were transiently transfected with plasmids (10 μg per plasmid) using the Nucleofector II machine and manufacturer’s protocols (Amaxa). Huh7 cells (1×106 per reaction) were nucleofected using Kit V and protocol T-022. MEF cells (1×106 per reaction) were nucleofected using Kit V and protocol T-020. Each transfection reaction was divided into two or three wells. A GFP-expressing plasmid was used as transfection control and reactions were used for experiments if GFP positive cells numbered >90%.
+ Open protocol
+ Expand
2

Transfection of Sarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GIST-T1, GIST430, RMS176, LMS04 and EWS502 cell monolayers were disaggregated with trypsin and resuspended in Amaxa Nucleofector solution V (Amaxa Biosystems) at a concentration of 1 × 106 cells per 100 μl. Nucleofection was performed using program T-030 on a Nucleofector II machine (Amaxa Biosystems). One microgram of pCR3.1-EGFP or pCR3.1-miniDMD plasmid was used for electroporation. Transfected cells were selected with G418 for 5 days before analyses.
+ Open protocol
+ Expand
3

Transfection of Sarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GIST-T1, GIST430, RMS176, LMS04 and EWS502 cell monolayers were disaggregated with trypsin and resuspended in Amaxa Nucleofector solution V (Amaxa Biosystems) at a concentration of 1 × 106 cells per 100 μl. Nucleofection was performed using program T-030 on a Nucleofector II machine (Amaxa Biosystems). One microgram of pCR3.1-EGFP or pCR3.1-miniDMD plasmid was used for electroporation. Transfected cells were selected with G418 for 5 days before analyses.
+ Open protocol
+ Expand
4

Knockdown of Dystroglycan in Kasumi-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
shRNA constructs targeting dystroglycan or control shRNA were generated using the RNAi- Ready pSiren-RetroQ system (Clontech Laboratories Inc. Palo Alto, CA, USA) and have been described previously [9 (link)]. Kasumi-1 cells (2 × 106/ ml) were transfected with 2μg DNA mixed with 2 μg pEGFP-N1 to mark the shRNA transfected cell population (Clontech Laboratories Inc. Palo Alto, CA, USA) on the Nucleofector II machine (Amaxa), according to the manufacturer's recommendation (Lonza Walkerrsville Inc. Walkersville, MD). Twenty-four hours after transfection cells were selected for cell sorting (Moflo XDP, Beckman Coulter, Brea, CA, USA). For functional assays, selected cells were differentiated for 7 d.
+ Open protocol
+ Expand
5

Efficient NSC Electroporation for Protein Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Electroporations were performed on 4 million trypsinized NSCs resuspended in Mouse Nucleofector solution (Lonza VPG-1004) with 7 μg of Endotoxin-free DNA using the Mouse Neural Stem cell program in the Nucleofector II machine (Lonza). Electroporations were plated immediately onto glassware coated with PLO and laminin with a media change 24 hours later to remove dead cells. In overexpression experiments of varying aggregation-prone proteins, cells were imaged 24–48 hours after electroporation.
+ Open protocol
+ Expand
6

Transfection and Transduction of Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the pCMV6-XL5 cloning vector (OriGene, Rockville, MD, USA), transfection was performed using a Nucleofector II machine (LONZA, Cologne, Germany). 6 × 105 HeLa MDR-Off, KB-8-5-11 and KB-C1 cells were used for each point transfection through Amaxa® Cell Line Nucleofector® Kit R and the protocol was performed as recommended by the manufacturer. Empty vector with or without GFP was used as a control for transfection.
HeLa cell transductions with BacMam-Pgp virus wild-type and E556Q/ E1206Q mutants were performed as described previously [26 (link), 27 (link)].
+ Open protocol
+ Expand
7

Enhancing Treg Function via RLTPR Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 10

Tregs were contacted with either 2.5 μg of control GFP plasmid or 1 μM, 5 μM, or 10 RLTPR siRNA per 100 μL. Cells were then placed in Lonza cuvettes (100 μL per cuvette) and electroporated using program X-001 in a Lonza Nucleofector II machine. After transfection, cells were placed in 2 mL of warmed complete Amaxa media (5% FBS, Pen/Strep, 10 μL/mL of Lonza media supplement) in a 12-well plate and incubated at 37° C. for 4 hours. After 4 hours, cells were removed from the wells, spun down (1500 RPM for 5 minutes), then diluted in 2 mL of warmed Amaxa complete media supplemented with 300 IU/mL recombinant human IL-2 and plated on a 12-well placed coated with anti-CD3 and anti-CD28 (10 μg/mL of each antibody). 24 hours after transfection (2D), 1 mL of Lonza complete media with 300 IU rhIL-2 was added to each well. 48 hours after transfection (3D), cells were removed from the wells and counted. The cells contacted with the 10 μM of RLTPR siRNA were used in functional studies.

FIGS. 5A-5D show that RLTPR siRNA significantly decreased RLTPR protein levels in Tregs. Results also demonstrated that RLTPR siRNA treatment (at 10 μM) increased in vitro suppressive function (see FIGS. 6A and 6B) and augmented Nrp1 (see FIG. 7C).

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!